Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | GGT1 | P19440 | 1/20 | 0.40 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.38 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL472934 | 1.00 | FOLH1 (0.50) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| SCHEMBL472937 | 1.00 | FOLH1 (0.50) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| SCHEMBL1054672 | 0.93 | FOLH1 (0.58) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| SCHEMBL48407 | 0.93 | FOLH1 (0.58) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| SCHEMBL48406 | 0.93 | FOLH1 (0.58) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| Ammonia Solution, Strong SCHEMBL6151757 | 0.91 | FOLH1 (0.56) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| Hydrochloric Acid SCHEMBL4067567 | 0.91 | FOLH1 (0.56) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| Hydrochloric Acid SCHEMBL16732003 | 0.91 | FOLH1 (0.56) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| Methane SCHEMBL28201404 | 0.91 | FOLH1 (0.56) | FOLH1CPB2GSRRNPEPSLC6A5 | |
| Hydrochloric Acid SCHEMBL4067569 | 0.91 | FOLH1 (0.56) | FOLH1CPB2GSRRNPEPSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108853139-A | The medical composition and its use of various trace elements VII | 刘力 | 2018-11-23 | — | — | CN | claimed |
| CN-108653259-A | The medical composition and its use of various trace elements IV | 刘力 | 2018-10-16 | — | — | CN | claimed |
| CN-107789365-A | The medical composition and its use of various trace elements V | 刘力 | 2018-03-13 | — | — | CN | claimed |
| CN-107773571-A | The medical composition and its use of various trace elements IV | 胡梨芳 | 2018-03-09 | — | — | CN | claimed |
| CN-106520751-A | Preparation method and application of immobilized iron chelate enzyme | 浙江医药高等专科学校 | 2017-03-22 | — | — | CN | claimed |
| US-20150354024-A1 | METHODS FOR BINDING AND PRECIPITATING GOLD USING MICROBIAL-DERIVED METALLOPHORES AND THEIR USES | MCMASTER UNIVERSITY (CA) | 2015-12-10 | — | — | US | claimed |
| WO-2015078889-A1 | NEW ENZYMES AND METHOD FOR PREPARING HYDROXYLATED L-LYSINE OR L-ORNITHINE AND ANALOGS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-06-04 | — | — | WO | claimed |
| EP-2876156-A1 | New enzymes and method for preparing hydroxylated L-lysine or L-ornithine and analogs thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-27 | — | — | EP | claimed |
| WO-2014107814-A1 | METHODS FOR BINDING AND PRECIPITATING GOLD USING MICROBIAL-DERIVED METALLOPHORES AND THEIR USES | MCMASTER UNIVERSITY (CA) | 2014-07-17 | — | — | WO | claimed |
| CN-1303991-C | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative process for preparing the same | WARNER LAMBERT CO (US) | 2007-03-14 | — | — | CN | claimed |
| EP-1077692-B1 | AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME | WARNER LAMBERT CO (US) | 2004-07-28 | — | — | EP | claimed |
| CN-1301155-A | Stable pharmaceutical formulation of gamma-aminobutyric acid derivatives and process for preparing the same | WARNER LAMBERT CO (US) | 2001-06-27 | — | — | CN | claimed |
| EP-1077692-A1 | AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME | Warner-Lambert Company LLC (US) | 2001-02-28 | — | — | EP | claimed |
| WO-1999059573-A9 | STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | WARNER LAMBERT CO (US) | 2000-05-04 | — | — | WO | claimed |
| WO-1999059573-A1 | STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | WARNER-LAMBERT COMPANY (US) | 1999-11-25 | — | — | WO | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| EP-0144750-B1 | ANTIBIOTICS, METHOD FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND INTERMEDIATES FOR THEIR PREPARATION | BAYER AG (DE) | 1988-06-08 | — | — | EP | claimed |
| EP-0144750-A2 | Antibiotics, method for their preparation, their use as medicines and intermediates for their preparation | BAYER AG (DE) | 1985-06-19 | — | — | EP | claimed |
| US-12383522-B2 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | AMNEAL PHARMACEUTICALS LLC (US) | 2025-08-12 | — | — | US | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383522-B2 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | GABRB1, GABRB2, GABBR1 | FOLH1 762/4885CPB2 1390/4885GSR 1890/4885 |
| US-20150354024-A1 | METHODS FOR BINDING AND PRECIPITATING GOLD USING MICROBIAL-DERIVED METALLOPHORES AND THEIR USES | SPR, LGALS3BP, MB | FOLH1 606/4885CPB2 2011/4885GSR 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.